HC refuses to hear plea seeking uniform rate of COVID-19 vaccines
The Hindu
The Bombay High Court on Thursday refused to hear a public interest litigation (PIL) petition seeking to quash the different rates of COVID-19 vaccines by Serum Institute of India (SII) and Bharat Bio
The Bombay High Court on Thursday refused to hear a public interest litigation (PIL) petition seeking to quash the different rates of COVID-19 vaccines by Serum Institute of India (SII) and Bharat Biotech for the Centre and State governments and fix the price at ₹150 per dose. A Division Bench of Chief Justice Dipankar Datta and Justice G.S. Kulkarni said, “The Supreme Court has said that issues that have pan-India effect will be dealt with by it and pricing is a phenomenon applicable all over India. We are not entertaining it (PIL) as the apex court has fairly covered it.”More Related News
The event will run daily from 10 a.m. to 8.30 p.m., offering a variety of activities. Visitors can enjoy dance and music performances, hands-on art experiences, film screenings, and exhibitions from 10.30 a.m. to 6.30 p.m. These will feature folk cuisines, leather puppets, philately, textiles, and handicrafts.